The present study showed a novel finding that the development of adjuvant-induced arthritis (AA) in Lewis rats was completely prevented by incomplete Freund's adjuvant (IFA) injected 21 or 28 days before complete Freund's adjuvant (CFA) challenge. Hexadecane also completely prevented AA and squalane, methyl oleate and pristane moderately prevented AA, though pristane by itself induced mild arthritis in two out of five rats. Concanavalin A-stimulated lymph node cells (LNCs) isolated from AA rats were able to adoptively transfer the severe polyarthritis to all the naive recipients or even to the IFA pretreated recipients with earlier onset and more rapid progression than those of AA. The LNCs from the donors who had been pretreated with IFA and subsequently challenged with CFA could induce mild arthritis in only two out of eight naive recipients, whereas all the recipients who were challenged with CFA immediately after intravenous injection of these LNCs developed significantly less severe arthritis. However, the LNCs from IFA-pretreated donors failed to prevent AA. According to the T helper type 1 ( Th1)/Th2 paradigm, it was suggested that the adjuvant-active vehicles such as IFA, hexadecane, squalane, methyl oleate and pristane, can affect and deviate the Th1/Th2 balance of immune responses in host. CFA could promote the propagation of Th2 cells rather than Th1 cells in these vehiclepretreated rats through as yet undetermined mechanisms, eventually resulting in the prevention of AA. Finally, we discussed a regulatory role of adjuvant vehicles for induction and suppression of AA.
INTRODUCTION
synthetic mineral oil, could induce severe and chronic arthritis in various rats or in mice, known as pristane-induced arthritis Adjuvant-induced arthritis (AA) in Lewis rats is a model of (PIA)4,5 and lipoidal amine (avridine), a strong interferon T-cell-mediated autoimmune disease resembling human rheuinducer, could induce polyarthritis in Lewis rats, known as matoid arthritis (RA). AA can be induced by a single intraderavridine-induced arthritis (AIA). 6 The clinical course and mal (i.d.) injection of complete Freund's adjuvant (CFA) histology of OIA, PIA and AIA are indistinguishable from consisting of Mycobacterium tuberculosis (Mt) and incomplete those of AA. 3, 4, 6 The fact that OIA and AIA as well as AA Freund's adjuvant (IFA) but AA cannot be induced by can be passively transferred in the naive rats by the lymph injection of IFA alone in the Lewis rats,1 suggesting the node cells (LNCs) or spleen cells derived from arthritic rats importance of Mt as an antigen and IFA as a coadjuvant.2 suggests the involvement of immunological mechanisms for However, an i.d. injection of IFA alone was able to induce induction of these forms of arthritis.7-9 However, it is as yet polyarthritis in DA rats, known as oil-induced arthritis (OIA). 3 uncertain what the specific antigen responsible for induction Similarly, it was also reported that pristane, a well-defined of these forms of arthritis might be, because IFA, pristane and other vehicles by themselves are intrinsically inert as
MATERIALS AND METHODS
(Flow Laboratories, Paisley, UK ). The medium was supplemented with 100 mg/ml streptomycin, 100 U/ml penicillin Animals G, 5×10−5  2-mercaptoethanol, 1% non-essential amino Inbred Lewis rats were obtained from Charles River Japan, acid, and 10% heat-inactivated fetal calf serum (FCS) Inc. (Shiga, Japan). They were housed at the Center for (Intergen Purchase, Kobe, Japan). Flasks were incubated at Laboratory Animals of Saga Medical School, fed a sterile 37°in a humidified, 5% CO 2 atmosphere. After 48 hr incucommercial diet and water ad libitum, and maintained by bation, LNCs were harvested from cultured flasks by centrifucontinuous brother and sister mating under specific pathogengation and were washed twice with PBS, then 1·5×108 viable free conditions. At the age of 3-4 weeks females and males cells were resuspended in 1 ml PBS before intravenous injection were separated and only females (7-10 weeks) were used in into the tail vein of each syngeneic female recipient rat. After the experiments described here. the transfer of LNCs, each recipient rat was examined daily and assigned a daily numerical clinical score based on the Preparation of CFA and induction of AA method described above.12 Except for the preinjected left paw, Mycobacterium tuberculosis H37 Ra (Mt) and IFA were the highest achievable clinical scores would be 12. purchased from Difco Laboratories (Detroit, MI ). The CFA was prepared as follows: 10 mg of H37 Ra was ground with Histology a mortar and pestle and IFA was added drop by drop to a
The rats were killed under ether anaesthesia. Spleen, ILNs, final volume of 1 ml. This preparation was kept in an incubator paws and liver were fixed in 10% buffered formalin phosphate, at 42°for 72 hr to improve the solubility of Mt in IFA. An for at least 2 days before decalcification. After decalcification, equal volume of phosphate-buffered saline (PBS ) was added the sections were cut with a cryotome and then stained with drop by drop with continuous mixing in this preparation to haematoxylin and eosin. The stained sections were examined make a good water-in-oil emulsion. For induction of AA, the under a microscope for histopathological changes in the organs rats were intradermally injected at the base of the tail with as previously described.13 0·1 ml of CFA.
Statistical analysis Pretreatment of IFA or various vehicles
Statistical analyses were conducted by using a commercially Squalane, pristane, methyl oleate and n-hexadecane were puravailable microcomputer program ( 4·5). Significant chased from Wako Pure Chemical Industries, Ltd, Kobe, differences in arthritic score between two groups were deterJapan). IFA and these vehicles were injected without forming mined at each point by the two-tailed Student's t-test, and a an emulsion. The rats were intradermally injected in the left P value of less then 0·05 was taken as significance. footpad with 50 ml of these various vehicles on the indicated days (1, 7, 14, 21, or 28 days) before CFA administration (day 0).
RESULTS
Preventive effect of IFA on AA Clinical evaluation of AA The severity of polyarthritis was assessed by standard methodAll the rats developed the severe AA after i.d. immunization ology.12 Each paw was graded from 0 to 4 based on erythema, of CFA, whereas none of the rats (0/15) developed the disease swelling and deformity of the joint. except the preinjected left when CFA was immunized i.d. 28 days after IFA adminispaw. The highest achievable clinical scores would be 12. The tration ( Fig. 1 ), indicating that IFA pretreatment completely rats were observed and scored every other day in a blinded prevented the development of AA. When IFA was intraderfashion.
mally injected 1, 7, 14, 21, or 28 days before CFA challenge, respectively ( Table 1) , all the rats which were pretreated with Adoptive transfer of AA with the concanavalin A-stimulated IFA 1 day before CFA challenge developed significantly less LNCs from various donors severe arthritis with delayed onset than that of the no pretreatThe adoptive transfer experiments were carried out according ment rats. The rats which were pretreated with IFA 7 days or to the method of Taurog et al. 8, 9 We used three different groups of donors in our experiments. In one group, donors received 0·1 ml of CFA injected i.d. into the tail base. In the tration of 3×106 cells/ml in 50 ml of RPMI-1640 medium 14 days before CFA challenge developed much less severe developed the severe arthritis. The disease appeared 4-7 days after cell transfer and rapidly became severe within a few days. arthritis with lower incidence. None of the rats which were pretreated with IFA 21 or 28 days before CFA challenge
The same LNCs also induced severe arthritis in all the recipients who were pretreated with IFA 28 days before cell transfer developed the disease.
(group 2). On the other hand, only two out of eight recipients (group 3) developed significantly milder arthritis after intraPreventive effects of various vehicles on the development of AA venous injection of the LNCs from the donors which had been pretreated with IFA and subsequently challenged with CFA. It is known that hexadecane, pristane, methyl oleate and squalane can be exchanged for IFA as a coadjuvant for the However, when the recipients (group 4) were immunized with CFA immediately after the intravenous injection of the same induction of AA or experimental allergic encephalomyelitis (EAE).2 We were interested to know whether or not these LNCs as in group 3, all the recipients developed much less severe disease than that of group 3 (P<0·05). Finally, the vehicles can also prevent the development of AA as IFA did. As shown in Table 2 , hexadecane could completely prevent
LNCs from the IFA-pretreated alone, without CFA challenge, donors never prevented the development of AA in the CFAthe development of AA. Methyl oleate prevented AA with lower incidence and significantly milder severity than that in challenged recipients (group 5). the control group. Squalane could significantly reduce the severity of the disease in all of the rats. Pristane by itself Histological studies induced very mild arthritis in two out of five rats (known as PIA4), whereas the other three rats did not develop the disease In Fig. 2(b) and (d), all the rats were injected intravenously with the LNCs from AA rats. Figure 2 (b) (adoptively transeven after CFA challenge. ferred arthritis) showed the basically indistinguishable pathological changes of typical AA (Fig. 2a ). There were various Effects of LNCs from differently treated donors on induction or degrees of synovitis, tendinitis, periostitis and para-articular prevention of arthritis tissue granulation with eosinophilic fibrinous mass in the joint spaces, the predominant polymorpholeucocyte infiltration, As shown in Table 3 , all the rats injected with 1·5×108 of Con A-stimulated LNCs derived from AA donors (group 1) intense connective tissue proliferation with pannus formation The rats were intradermally injected in the left footpad with the vehicle indicated 28 days before CFA challenge. Each group consisted of five rats. Arthritis score was measured every other day, as described in the Materials and Methods. *Acute swelling after vehicle injection appeared in 24 hr and disappeared within 3-4 days. −, no swelling; +, mild; ++, severe; +++, very severe. †pristane by itself induced polyarthritis in two out of five rats that was known to be PIA.4 and subsynovial vascular dilatations and new bone formation. DISCUSSION In contrast to these pathological changes, Fig. 2(c) (IFApretreated and CFA-challenged rats) showed no obvious
The present study showed a novel finding that pretreatment with IFA or hexadecane completely prevented the development inflammation or pathological changes. Figure 2 (d ) (rats IFApretreated followed by passive transferral of LNCs) showed of AA in Lewis rats and other vehicles, such as squalane, methyl oleate and pristane, also moderately prevented AA. As similar changes to Fig. 2(a) and (b) . a coadjuvant, it has been shown that IFA could be exchanged balance is somewhat similar to the concept of immune deviation proposed by Asherson.24 On the other hand, since IFA by many other vehicles, such as hexadecane, methyl oleate, squalane and pristane, for induction of AA given with mycowas able not only to induce arthritis,15 but also to prevent the development of AA in DA rats,25 it is possible that IFA and bacterial antigens and for induction of EAE given with myelin basic proteins.2,14 Surprisingly, an i.d. injection of IFA could other vehicles described above induce non-specific inflammations, exert their adjuvant activities to potentiate and induce severe polyarthritis in the highly susceptible DA rats without mycobacterial antigens but not in Lewis rats. 3, 15 This attenuate the reactivity of the host immune responses and then the subsequent administration of CFA may propagate the oil-induced arthritis (OIA) is clinically and histologically indistinguishable from AA. By using DA, Lewis, F 1 and F 2 attenuated host immune responses to prevent AA in the Lewis rats, possibly through the cytokine networks.11 With regard intercross rats, it was suggested that the susceptible genes of rat for OIA are located both within and outside the major to cytokines, it is well-known that Th1-type cytokines [interferon-c, interleukin-2 (IL-2)] are essentially involved in the histocompatibility complex (MHC; Oia 1).16 Furthermore, without any additional exogenous antigens, pristane could development of some autoimmune diseases (type 1 diabetes, EAE, RA, multiple sclerosis, etc.), whereas Th2-type cytokines induce polyarthritis in rats and mice.4,5 The PIA was partly confirmed in the present study (Table 2) . Avridine ( lipoidal (IL-4, IL-10, IL-13) are associated with other types of immune diseases (progressive systemic sclerosis, systemic lupus eryamine), a strong interferon inducer, could also induce polyarthritis in rats that was known as AIA.6 OIA, AIA and AA thematosus, experimental autoimmune uveoretinitis, etc.).10,26 Furthermore, IL-6 is a multifunctional cytokine and plays an could be passively transferred to either irradiated rats or naive rats by LNCs from the diseased rats, indicating that T-cellimportant role in induction of polyclonal B-cell abnormalities and autoimmune diseases.27,28 Therefore it is very important mediated immune responses may play a very important role for induction of these arthritides.6-9,15 However, the antigenic to elucidate the role of cytokines as well as of T cells for understanding the immunopathological mechanisms of autospecificity of these T cells responsible for the induction and propagation of the diseases has not yet been defined in these immune diseases.
Another possibility is that the IFA and other vehicles models,17 though it has been reported that the arthritisinducing T-cell clone could response to 65 000 MW mycoexerted their adjuvant activity as a stress to up-regulate the expression of endogenous self-heat-shock protein (hsp 60),29 bacterial heat-shock protein,18 type II collagen19 and cartilage proteoglycans. 20 and therefore the regulatory T cells which could respond to both mycobacterial hsp 65 and self-hsp 60 were activated to Our present study confirmed that an intravenous injection of LNCs from the diseased rats could transfer AA to the naive protect AA through some still uncertain mechanisms.30,31 In summary, the present studies showed that the pretreatLewis rats, all of which developed very severe arthritis with much earlier onset than that of AA. In spite of the finding ment of various adjuvant active vehicles, such as IFA, hexadecane, squalane, methyl oleate, or pristane, could prevent the that IFA pretreatment completely prevented the development of AA (Table 1) , the IFA pretreated recipients could develop development of AA and this preventive effect could be passively transferred by LNCs, possibly through affect, and deviate AA by passively transferred LNCs from AA rats. Furthermore, the LNCs from the IFA-pretreated donors could not prevent the Th1/Th2 balance of immune responses, resulting in the Th1 bias responsible for production of arthritis, as in the DA the development of AA in the CFA-challenged recipients. These findings suggested that the administration of IFA in rats,23 or in the Th2 bias responsible for preventing AA, as in Lewis rats. Alternatively, these immunologically active vehicles Lewis rats can neither induce AA nor regulate the development of AA until these IFA-pretreated rats encounter some other stimulate host tissue inflammation strongly enough to generate various cytokines and to make some endogenous self-antigens additional stimuli, such as CFA. This hypothesis was supported in the present studies by the finding that the LNCs from the described above into strong immunogens or modified selfantigens, resulting in the regulation of autoimmune disease IFA-pretreated and subsequently CFA-challenged donors could induce less severe AA in only two out of eight naive through induction or suppression. We are continuing to clone the T cells responsible for either induction or suppression of recipients, whereas all the recipients which were challenged with CFA immediately after intravenous injection of these AA for future therapeutic models of human rheumatoid arthritis. LNCs developed the disease, even with significantly less severity (P<0·05). Since AA is mediated by Th1 cells or Th1-type cytokines21,22 and polyclonal Th1 cells can transfer OIA to ACKNOWLEDGMENTS the naive DA rats,23 the present findings suggested in the 
